Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FMCG, capital goods weigh on markets
Tue, 26 Apr 11:30 am

Indian stock markets continued to flounder in the red on the back of profit booking in heavy weights over the last two hours of trade. Stocks from the FMCG and capital goods space are the biggest losers while stocks from the realty and IT space have lost the least.

The BSE-Sensex is down by 212 points while NSE-Nifty is trading 66 points below the dotted line. BSE Midcap index is trading down by 0.4% while BSE Small cap index is trading 0.5% below yesterday's closing. The rupee is trading at 44.58 to the US dollar.

Auto stocks are trading in the red with M&M and Maruti Suzuki leading the losses. As per a leading financial daily, Mahindra & Mahindra is planning to set up production facilities in Africa. The company wants to establish plants in Tunisia, Morocco, South Africa, Kenya, Ethiopia and Zambia. It may be noted that Mahindra already has plants in Gambia, Tchad, Mali, Ghana and Nigeria. In fact, the tractor company is present in 24 out of the 53 countries of the continent. It gets 15% of its exports from Africa and aims to double it in a year's time.

The company management stated that the company is following a bottom of the pyramid strategy in the opportunistic market of Africa. The demand they feel will arise out of the growing disposable incomes of the people residing there. The company will be focusing on three-wheelers, light commercial vehicles and utility vehicle Bolero for this market. It is also in the process of appointing a country manager along with a team of 7-8 people to handle this expansion plan.

FMCG stocks are trading weak led by Gillette India and Hindustan Unilever. Procter and Gamble Hygiene and Health Care Limited (PGHHCL) released its 3QFY11 results. The company's top line grew by 14.3% YoY. This performance came on the back of a 21% YoY volume growth partially offset by price cuts and increase in excise duty. The company's Feminine Hygiene segment posted a 23% YoY growth for the quarter driven by strong demand for Whisper Choice and Whisper Ultra. Health Care business of PGHHCL also performed well with a growth of 11% YoY on the back of 28% YoY growth in Vicks Cough drops and 24% YoY growth in Vicks Inhalers. Operating income of the company grew by 6% YoY. While advertisement and staff costs fell by 14% YoY and 5% YoY respectively, other expenditure grew by a tepid 11% YoY. However, sharp increase in cost of goods sold by 50% YoY on the back of increase in commodity costs resulted in operating income growing slower than sales. Net profit of PGHHCL fell by 10.8% YoY on the back of lower operating income, fall in other income and rise in depreciation costs. Net profits would have been lower but for a fall in effective tax rate.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "FMCG, capital goods weigh on markets". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.